ReShape Lifesciences Announces $10 Million Registered Direct Offering
Stockhouse
… metabolic diseases, today announced that it has entered into definitive agreements with two healthcare focused institutional investors for the purchase of 8,000,000 shares of its common stock and warrants to purchase 8,000,000 shares of its common …
